[Oral immunization against classical swine fever (CSF) in the Federal State of Brandenburg from 1995 to 1997].
The first findings of classical swine fever in wild boar occurred in the rural district Ostprignitz-Ruppin of Brandenburg in March 1995. Up to this time the area was considered to be free of swine fever in domestic and wild boars. The swine fever cases were marked particularly by the occurence of dead games and clinically decreased individuals as well as by the involvement of young wild boars. (< 10 kg carcass weight). In Brandenburg, the eradication programme of classical swine fever was based on oral immunization with an attenuated type C vaccine (so called Dessauer wild boar lure) carried out within the frame of a field trial since 1995. The success of oral immunization was examined by the development of swine fever positive-findings within the swine fever endangered district and by the seroconversion in the entire vaccination area. Due to the oral immunization the classical swine fever prevalence decreased from 4.65% in March 1995 to 0.58% in December 1997. After the third immunization the seroconversion reached on average rates between 30% and 35%. The seroconversion increased with carcass weight and with number of subsequent immunization. During the investigation period the rate of seroconversion in wild boars up to 17 kg carcass weight was 13.2%, in wild boars from 18 to 28 kg carcass weight 23.1%, sub-adult wild boars from 29 to 56 kg carcass weight 33.2%, and the adult wild boars above 57 kg carcass weight 41.5%.
Kern
B
B
Staatliches Veterinär- und Lebensmitteluntersuchungsamt Potsdam Klinik für Klauentiere der Freien Universität Berlin.
Lahrmann
K H
KH
D000284:Administration, Oral; D000818:Animals; D000829:Animals, Domestic; D000835:Animals, Wild; D006691:Classical Swine Fever / Q000453:epidemiology / Q000276:immunology* / Q000517:prevention & control*; D005858:Germany / Q000453:epidemiology; D015994:Incidence; D013552:Swine; D014613:Vaccines, Attenuated / Q000008:administration & dosage*; D014765:Viral Vaccines / Q000008:administration & dosage*
D014613:Vaccines, Attenuated; D014765:Viral Vaccines